We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.07%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.62B
AUM Growth
+$83.9M
(+5.5%)
Cap. Flow
-$23.8M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
2,764
New
163
Increased
787
Reduced
971
Closed
110
Avg Time Held Equity + Options
2.4
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
1.6
years
Avg Time Held Equity only
2.4
years
Top 10 Avg Time Held Equity only
1.6
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$20M |
| 2 |
ONEM
1Life Healthcare
ONEM
|
+$9.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$9.31M |
| 4 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$5.82M |
| 5 |
Okta
OKTA
|
+$5.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$26.7M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$10.8M |
| 3 |
CVB Financial
CVBF
|
+$10.7M |
| 4 |
Apple
AAPL
|
+$3.81M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$3.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.59% |
| 2 | Technology | 13.63% |
| 3 | Financials | 7.56% |
| 4 | Healthcare | 6.26% |
| 5 | Consumer Discretionary | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Supernus Pharmaceuticals
SUPN
$2.3B
| $2K | ﹤0.01% |
76
| – | – |
2020 Q2
1 quarter
|
|
2327
Talos Energy
TALO
$2.84B
| $2K | ﹤0.01% |
285
+149
| +110% | +$1.09K |
2020 Q1
2 quarters
|
|
2328
DELISTED
Theravance Biopharma
TBPH
| $2K | ﹤0.01% |
158
| – | – |
2016 Q4
15 quarters
|
|
2329
DELISTED
TEGNA Inc
TGNA
| $2K | ﹤0.01% |
179
+53
| +42% | +$630 |
2016 Q4
15 quarters
|
|
2330
Travere Therapeutics
TVTX
$4.98B
| $2K | ﹤0.01% |
94
| – | – |
2020 Q2
1 quarter
|
|
2331
United Fire Group
UFCS
$1.42B
| $2K | ﹤0.01% |
81
-4
| -5% | -$100 |
2020 Q2
1 quarter
|
|
2332
Unifirst Corp
UNF
$4.79B
| $2K | ﹤0.01% |
12
| – | – |
2020 Q1
2 quarters
|
|
2333
Liberty All-Star Equity Fund
USA
$1.84B
| $2K | ﹤0.01% |
395
| – | – |
2020 Q2
1 quarter
|
|
2334
Cohen & Steers Infrastructure Fund
UTF
$2.85B
| $2K | ﹤0.01% |
104
| – | – |
2017 Q1
14 quarters
|
|
2335
Utah Medical Products
UTMD
$238M
| $2K | ﹤0.01% |
22
-153
| -87% | -$12.7K |
2020 Q1
2 quarters
|
|
2336
Walker & Dunlop
WD
$1.14B
| $2K | ﹤0.01% |
32
| – | – |
2018 Q3
8 quarters
|
|
2337
White Mountains Insurance
WTM
$5.12B
| $2K | ﹤0.01% |
3
| – | – |
2016 Q4
15 quarters
|
|
2338
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.88B
| $2K | ﹤0.01% |
+69
| New | +$2.46K |
2020 Q3
0 quarters
|
|
2339
Amplify CEF High Income ETF
YYY
$654M
| $2K | ﹤0.01% |
145
| – | – |
2020 Q2
1 quarter
|
|
2340
Zumiez
ZUMZ
$221M
| $2K | ﹤0.01% |
67
| – | – |
2020 Q2
1 quarter
|
|
2341
TXNM Energy Inc
TXNM
$6.45B
| $2K | ﹤0.01% |
45
+14
| +45% | +$584 |
2016 Q4
15 quarters
|
|
2342
United Community Banks
UCB
$4.11B
| $2K | ﹤0.01% |
130
-72
| -36% | -$1.3K |
2017 Q1
14 quarters
|
|
2343
DELISTED
Infinera Corporation Common Stock
INFN
| $2K | ﹤0.01% |
403
| – | – |
2018 Q4
7 quarters
|
|
2344
DELISTED
Brightcove, Inc.
BCOV
| $2K | ﹤0.01% |
224
+90
| +67% | +$898 |
2020 Q2
1 quarter
|
|
2345
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2K | ﹤0.01% |
+47
| New | +$2.06K |
2020 Q3
0 quarters
|
|
2346
DELISTED
SunPower Corporation Common Stock
SPWR
| $2K | ﹤0.01% |
163
-86
| -35% | -$724 |
2016 Q4
15 quarters
|
|
2347
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2K | ﹤0.01% |
19
| – | – |
2020 Q2
1 quarter
|
|
2348
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $2K | ﹤0.01% |
34
-22
| -39% | -$1.37K |
2019 Q3
4 quarters
|
|
2349
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $2K | ﹤0.01% |
40
-28
| -41% | -$1.37K |
2020 Q2
1 quarter
|
|
|
FIF
2350
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
| $2K | ﹤0.01% |
201
| – | – |
2020 Q2
1 quarter
|
|
Similar funds
Parallel Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Parallel Advisors held 2,764 positions worth $1.62B, up 5.5% from $1.53B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors's Q3 2020 filing shows 163 new, 787 increased, 971 reduced and 110 closed positions. Its largest new stake was 1Life Healthcare: 297,796 shares worth $8.45M. The largest sale was Microsoft, an estimated $26.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 54% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q3 2020 buy was 1Life Healthcare: 297,796 shares worth $8.45M.
- Parallel Advisors added most to iShares US Treasury Bond ETF in Q3 2020, an estimated $20M increase.
- Parallel Advisors's biggest Q3 2020 reduction was Microsoft, cutting an estimated $26.7M.
- Parallel Advisors fully exited Medallia, Inc. in Q3 2020, selling an estimated $851K.
- Parallel Advisors's ten largest holdings make up 35% of its $1.62B portfolio in Q3 2020.
- Parallel Advisors opened 163 new positions and closed 110 in Q3 2020.
- Parallel Advisors's portfolio value rose 5.5% quarter-over-quarter to $1.62B.
Based on Parallel Advisors's 13F filing for Q3 2020, filed 27 Oct 2020.